Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 02 2020
Historique:
received: 13 09 2019
accepted: 10 01 2020
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 13 11 2020
Statut: epublish

Résumé

The NAD-dependent deacetylase Sirtuin-2 (SIRT2) functions in diverse cellular processes including the cell cycle, metabolism, and has important roles in tumorigenesis and bacterial infection. SIRT2 predominantly resides in the cytoplasm but can also function in the nucleus. Consequently, SIRT2 localisation and its interacting partners may greatly impact its function and need to be defined more clearly. In this study we used mass spectrometry to determine the interactomes of SIRT2 in whole cells and in specific cellular fractions; cytoplasm, nucleus and chromatin. Using this approach, we identified novel interacting partners of SIRT2. These included a number of proteins that function in nuclear import. We show that multiple importins interact with and contribute to the basal nuclear shuttling of SIRT2 and that one of these, IPO7 is required for SIRT2 mediated H3K18 deacetylation in response to bacterial infection. Furthermore, we reveal that the unstructured C-terminus of SIRT2 negatively regulates importin-binding and nuclear transport. This study demonstrates that SIRT2 is actively transported into the nucleus via a process regulated by its C-terminus and provides a resource of SIRT2 interacting partners.

Identifiants

pubmed: 32042025
doi: 10.1038/s41598-020-58397-6
pii: 10.1038/s41598-020-58397-6
pmc: PMC7010746
doi:

Substances chimiques

Karyopherins 0
Sirtuin 2 EC 3.5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2034

Références

Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238 (2012).
pubmed: 22395773 pmcid: 4872805 doi: 10.1038/nrm3293
Sanders, B. D., Jackson, B. & Marmorstein, R. Structural basis for sirtuin function: What we know and what we don’t. Biochim. Biophys. Acta - Proteins Proteomics 1804, 1604–1616 (2010).
doi: 10.1016/j.bbapap.2009.09.009
Li, J. et al. Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2). PLoS One 10, e0139095 (2015).
pubmed: 26407304 pmcid: 4583397 doi: 10.1371/journal.pone.0139095
Flick, F. & Lüscher, B. Regulation of Sirtuin Function by Posttranslational Modifications. Front. Pharmacol. 3, 29 (2012).
pubmed: 22403547 pmcid: 3289391 doi: 10.3389/fphar.2012.00029
Pan, M., Yuan, H., Brent, M., Ding, E. C. & Marmorstein, R. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. J. Biol. Chem. 287, 2468–76 (2012).
pubmed: 22157016 doi: 10.1074/jbc.M111.285031
Inoue, T. et al. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 26, 945–957 (2007).
pubmed: 16909107 doi: 10.1038/sj.onc.1209857
Gomes, P., Fleming Outeiro, T. & Cavadas, C. Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism. Trends Pharmacol. Sci. 36, 756–768 (2015).
pubmed: 26538315 doi: 10.1016/j.tips.2015.08.001
Budayeva, H. G. & Cristea, I. M. Human Sirtuin 2 Localization, Transient Interactions, and Impact on the Proteome Point to Its Role in Intracellular Trafficking. Mol. Cell. Proteomics 15, 3107–3125 (2016).
pubmed: 27503897 pmcid: 5054338 doi: 10.1074/mcp.M116.061333
Liu, G. et al. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy. Antioxid. Redox Signal. 26, 849–863 (2017).
pubmed: 27460777 pmcid: 5444513 doi: 10.1089/ars.2016.6662
Lemos, V. et al. The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Hum. Mol. Genet. 26, 4105–4117 (2017).
pubmed: 28973648 doi: 10.1093/hmg/ddx298
North, B. J. & Verdin, E. Interphase Nucleo-Cytoplasmic Shuttling and Localization of SIRT2 during Mitosis. PLoS One 2, e784 (2007).
pubmed: 17726514 pmcid: 1949146 doi: 10.1371/journal.pone.0000784
Pereira, J. M. et al. Infection Reveals a Modification of SIRT2 Critical for Chromatin Association. Cell Rep. 23, 1124–1137 (2018).
pubmed: 29694890 pmcid: 5946459 doi: 10.1016/j.celrep.2018.03.116
Eskandarian, H. A. et al. A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection. Science (80-). 341, 1238858 (2013).
doi: 10.1126/science.1238858
Vaquero, A. et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256–1261 (2006).
pubmed: 16648462 pmcid: 1472900 doi: 10.1101/gad.1412706
Black, J. C., Mosley, A., Kitada, T., Washburn, M. & Carey, M. The SIRT2 Deacetylase Regulates Autoacetylation of p300. Mol. Cell 32, 449–455 (2008).
pubmed: 18995842 pmcid: 2645867 doi: 10.1016/j.molcel.2008.09.018
Peck, B. et al. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol. Cancer Ther. 9, 844–55 (2010).
pubmed: 20371709 doi: 10.1158/1535-7163.MCT-09-0971
Maxwell, M. M. et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986–3996 (2011).
pubmed: 21791548 pmcid: 3203628 doi: 10.1093/hmg/ddr326
Rack, J. G. M., Vanlinden, M. R., Lutter, T., Aasland, R. & Ziegler, M. Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform. J. Mol. Biol. 426, 1677–1691 (2014).
pubmed: 24177535 doi: 10.1016/j.jmb.2013.10.027
Damodaran, S. et al. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes. BMC Cancer 17, 874 (2017).
pubmed: 29262808 pmcid: 5738829 doi: 10.1186/s12885-017-3853-9
McGlynn, L. M. et al. SIRT2: Tumour suppressor or tumour promoter in operable breast cancer? Eur. J. Cancer 50, 290–301 (2014).
pubmed: 24183459 doi: 10.1016/j.ejca.2013.10.005
Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13, 2129–41 (2003).
pubmed: 12952881 pmcid: 403709 doi: 10.1101/gr.772403
Wang, T., Geng, S.-L., Guan, Y.-M. & Xu, W.-H. Deacetylation of metabolic enzymes by Sirt2 modulates pyruvate homeostasis to extend insect lifespan. Aging (Albany. NY). 10, 1053–1072 (2018).
pubmed: 29769432 pmcid: 5990394 doi: 10.18632/aging.101447
Lin, R. et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol. Cell 51, 506–518 (2013).
pubmed: 23932781 pmcid: 4180208 doi: 10.1016/j.molcel.2013.07.002
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K. & Horio, Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823–32 (2007).
pubmed: 17197703 doi: 10.1074/jbc.M609554200
Tennen, R. I., Berber, E. & Chua, K. F. Functional dissection of SIRT6: Identification of domains that regulate histone deacetylase activity and chromatin localization. Mech. Ageing Dev. 131, 185–192 (2010).
pubmed: 20117128 pmcid: 2846990 doi: 10.1016/j.mad.2010.01.006
Ardestani, P. M. & Liang, F. Sub-cellular localization, expression and functions of Sirt6 during the cell cycle in HeLa cells. Nucleus 3, 442–51 (2012).
pubmed: 22743824 pmcid: 3474665 doi: 10.4161/nucl.21134
Kiran, S. et al. Intracellular distribution of human SIRT7 and mapping of the nuclear/nucleolar localization signal. FEBS J. 280, 3451–3466 (2013).
pubmed: 23680022 doi: 10.1111/febs.12346
Head, P. E. et al. Sirtuin 2 mutations in human cancers impair its function in genome maintenance. J. Biol. Chem. 292, 9919–9931 (2017).
pubmed: 28461331 pmcid: 5473244 doi: 10.1074/jbc.M116.772566
Lange, A. et al. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282, 5101–5 (2007).
pubmed: 17170104 doi: 10.1074/jbc.R600026200
Jäkel, S. et al. The importin β/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J. 18, 2411–2423 (1999).
pubmed: 10228156 pmcid: 1171324 doi: 10.1093/emboj/18.9.2411
Mackmull, M.-T. et al. Landscape of nuclear transport receptor cargo specificity. Mol. Syst. Biol. 13, 962 (2017).
pubmed: 29254951 pmcid: 5740495 doi: 10.15252/msb.20177608
Chuderland, D., Konson, A. & Seger, R. Identification and Characterization of a General Nuclear Translocation Signal in Signaling Proteins. Mol. Cell 31, 850–861 (2008).
pubmed: 18760948 doi: 10.1016/j.molcel.2008.08.007
Lee, B. J. et al. Rules for Nuclear Localization Sequence Recognition by Karyopherinβ2. Cell 126, 543–558 (2006).
pubmed: 16901787 pmcid: 3442361 doi: 10.1016/j.cell.2006.05.049
Nakada, R., Hirano, H. & Matsuura, Y. Structure of importin-α bound to a non-classical nuclear localization signal of the influenza A virus nucleoprotein. Sci. Rep. 5, 15055 (2015).
pubmed: 26456934 pmcid: 4601014 doi: 10.1038/srep15055
Sankhala, R. S. et al. Three-dimensional context rather than NLS amino acid sequence determines importin α subtype specificity for RCC1. Nat. Commun. 8, 979 (2017).
pubmed: 29042532 pmcid: 5645467 doi: 10.1038/s41467-017-01057-7
Poon, I. K. H. & Jans, D. A. Regulation of Nuclear Transport: Central Role in Development and Transformation? Traffic 6, 173–186 (2005).
pubmed: 15702986 doi: 10.1111/j.1600-0854.2005.00268.x
Nahhas, F., Dryden, S. C., Abrams, J. & Tainsky, M. A. Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol. Cell. Biochem. 303, 221–230 (2007).
pubmed: 17516032 doi: 10.1007/s11010-007-9478-6
Pandithage, R. et al. The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915–29 (2008).
pubmed: 18332217 pmcid: 2265402 doi: 10.1083/jcb.200707126
Baeuerle, P. A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta - Rev. Cancer 1072, 63–80 (1991).
doi: 10.1016/0304-419X(91)90007-8
Zhu, J. et al. Intramolecular Masking of Nuclear Import Signal on NF-AT4 by Casein Kinase I and MEKK1. Cell 93, 851–861 (1998).
pubmed: 9630228 doi: 10.1016/S0092-8674(00)81445-2
Imaoka, N. et al. Prognostic significance of sirtuin 2 protein nuclear localization in glioma: An immunohistochemical study. Oncol. Rep. 28, 923–930 (2012).
pubmed: 22735931 doi: 10.3892/or.2012.1872
Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878 pmcid: 30371878 doi: 10.1093/nar/gky1015
Jeong, J.-Y. et al. One-step sequence- and ligation-independent cloning as a rapid and versatile cloning method for functional genomics studies. Appl. Environ. Microbiol. 78, 5440–3 (2012).
pubmed: 22610439 pmcid: 3416421 doi: 10.1128/AEM.00844-12
Kowarz, E., Löscher, D. & Marschalek, R. Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines. Biotechnol. J. 10, 647–653 (2015).
doi: 10.1002/biot.201400821
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 pmcid: 19029910 doi: 10.1038/nbt.1511
Hein, M. Y. et al. Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ. Mol. Cell. Proteomics 13, 2513–2526 (2014).
pubmed: 24942700 pmcid: 4159666 doi: 10.1074/mcp.M113.031591
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nature Methods 13, 731–740 (2016).
pubmed: 27348712 doi: 10.1038/nmeth.3901
Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
pubmed: 1794559 pmcid: 1794559 doi: 10.1186/gb-2006-7-10-r100
Vizcaíno, J. A. et al. 2016 Update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447–D456 (2016).
pubmed: 26527722 doi: 10.1093/nar/gkv1145

Auteurs

Matthew J G Eldridge (MJG)

Pasteur, Chromatine et Infection G5, Paris, France.
Institut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.

Jorge M Pereira (JM)

Pasteur, Chromatine et Infection G5, Paris, France.
Institut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.
Laboratory of Molecular Microbiology, Global Health Institute, School of Life Sciences, Station 19, EPFL-SV-UPBLO, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Francis Impens (F)

Institut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.
VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.

Mélanie A Hamon (MA)

Pasteur, Chromatine et Infection G5, Paris, France. melanie.hamon@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH